These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26299928)

  • 1. Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease.
    Tanji K; Miki Y; Maruyama A; Mimura J; Matsumiya T; Mori F; Imaizumi T; Itoh K; Wakabayashi K
    Biochem Biophys Res Commun; 2015 Oct; 465(4):746-52. PubMed ID: 26299928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NUB1 in α-synuclein degradation in Lewy body disease model mice.
    Tanji K; Miki Y; Maruyama A; Mori F; Mimura J; Itoh K; Kamitani T; Wakabayashi K
    Biochem Biophys Res Commun; 2016 Feb; 470(3):635-642. PubMed ID: 26797281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.
    Spencer B; Potkar R; Trejo M; Rockenstein E; Patrick C; Gindi R; Adame A; Wyss-Coray T; Masliah E
    J Neurosci; 2009 Oct; 29(43):13578-88. PubMed ID: 19864570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation.
    Yoon YS; Cho ED; Jung Ahn W; Won Lee K; Lee SJ; Lee HJ
    Cell Death Dis; 2017 Oct; 8(10):e3091. PubMed ID: 28981090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
    Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
    PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
    Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
    Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
    Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability.
    Chen CM; Lin CH; Wu YR; Yen CY; Huang YT; Lin JL; Lin CY; Chen WL; Chao CY; Lee-Chen GJ; Su MT; Chang KH
    Cells; 2020 May; 9(5):. PubMed ID: 32429337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
    Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J
    Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple system atrophy and autophagy].
    Wakabayashi K; Tanji K
    Rinsho Shinkeigaku; 2014; 54(12):966-8. PubMed ID: 25519958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia.
    Oh CK; Dolatabadi N; Cieplak P; Diaz-Meco MT; Moscat J; Nolan JP; Nakamura T; Lipton SA
    J Neurosci; 2022 Apr; 42(14):3011-3024. PubMed ID: 35169022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of trehalose against Mn-induced α-synuclein oligomerization in mice: Involvement of oxidative stress and autophagy.
    Jing MJ; Liu K; Liu C; Yan DY; Ma Z; Wang C; Deng Y; Liu W; Xu B
    Environ Toxicol; 2020 Jan; 35(1):55-65. PubMed ID: 31497924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway.
    Klucken J; Poehler AM; Ebrahimi-Fakhari D; Schneider J; Nuber S; Rockenstein E; Schlötzer-Schrehardt U; Hyman BT; McLean PJ; Masliah E; Winkler J
    Autophagy; 2012 May; 8(5):754-66. PubMed ID: 22647715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease.
    Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
    Neurobiol Dis; 2011 Sep; 43(3):690-7. PubMed ID: 21684337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of Upstream Autophagy-Related Proteins (ULK1, ULK2, Beclin1, VPS34 and AMBRA1) in Lewy Body Disease.
    Miki Y; Tanji K; Mori F; Utsumi J; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Brain Pathol; 2016 May; 26(3):359-70. PubMed ID: 26260450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
    Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
    Kahle PJ; Neumann M; Ozmen L; Müller V; Odoy S; Okamoto N; Jacobsen H; Iwatsubo T; Trojanowski JQ; Takahashi H; Wakabayashi K; Bogdanovic N; Riederer P; Kretzschmar HA; Haass C
    Am J Pathol; 2001 Dec; 159(6):2215-25. PubMed ID: 11733371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy mediators (FOXO1, SESN3 and TSC2) in Lewy body disease and aging.
    Miki Y; Tanji K; Mori F; Utsumi J; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2018 Sep; 684():35-41. PubMed ID: 29966750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
    Anderson JP; Walker DE; Goldstein JM; de Laat R; Banducci K; Caccavello RJ; Barbour R; Huang J; Kling K; Lee M; Diep L; Keim PS; Shen X; Chataway T; Schlossmacher MG; Seubert P; Schenk D; Sinha S; Gai WP; Chilcote TJ
    J Biol Chem; 2006 Oct; 281(40):29739-52. PubMed ID: 16847063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.